semaglutide
Oral Semaglutide Cuts Pediatric BMI by Nearly 3 kg/m² in 12-Month Trial In a randomized, placebo-controlled phase-2 study of 126 adolescents, the once-daily tablet produced a mean 2.8 kg/m² drop in BMI after one year - a 6.5% shift in percentile that outperformed lifestyle counseling alone
semaglutide
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Hook Imagine a clinic where the physician finishes the day with the same paperwork load but two extra patient slots on the schedule. AI-driven scribes
semaglutide
When a drug that normally lives in a pen suddenly shows up as a chew-able tablet for teens, Wall Street takes notice. In early 2024, Novo Nordisk’s oral semaglutide trial in adolescents delivered a headline-worthy BMI-z drop, and the market responded faster than a teenager’s appetite after lunch.